Ionis Pharmaceuticals (IONS)
(Delayed Data from NSDQ)
$41.59 USD
-0.25 (-0.60%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $41.60 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Brokerage Reports
0 items in cart
Ionis Pharmaceuticals, Inc. [IONS]
Reports for Purchase
Showing records 61 - 70 ( 70 total )
Company: Ionis Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Ionis Pharmaceuticals, Inc.
Industry: Medical - Drugs
IONS Cardio-Renal Webcast Highlights Potential of LICA Platform, AGT-LRx Phase Two Readouts Expected By YE
Provider: Stifel Nicolaus Co., Inc.
Analyst: Research Department
Company: Ionis Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ionis Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Ionis Pharmaceuticals, Inc.
Industry: Medical - Drugs
Cardio-Renal Webcast Highlights Several Potentially Significant Opportunities
Provider: Piper Sandler
Analyst: Research Department
Company: Ionis Pharmaceuticals, Inc.
Industry: Medical - Drugs
Cardiovascular R-D Day Targets Safety Profile; Development Pathway for Factor XI
Provider: Oppenheimer & Co. Inc.
Analyst: Research Department
Company: Ionis Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Ionis Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Ionis Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Ionis Pharmaceuticals, Inc.
Industry: Medical - Drugs
Provider: Zacks Investment Research
Analyst: Research Department